United Therapeutics (NASDAQ:UTHR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
United Therapeutics beat estimated earnings by 50.6%, reporting an EPS of $5.03 versus an estimate of $3.34.
Revenue was up $82.80 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.21 which was followed by a 0.17% increase in the share price the next day.
Here's a look at United Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.72 | 3.59 | 3.02 | 2.94 |
| EPS Actual | 3.51 | 4.16 | 4.09 | 3.49 |
| Revenue Estimate | 427.62M | 421.45M | 378.75M | 368.95M |
| Revenue Actual | 415.20M | 444.70M | 446.50M | 379.10M |
To track all earnings releases for United Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
